AXON:NYE-Axovant Sciences Ltd. (USD)

EQUITY | Aerospace & Defense | New York Stock Exchange

Last Closing

USD 631.69

Change

0.00 (0.00)%

Market Cap

USD 1.28B

Volume

7.03M

Analyst Target

USD 4.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Axovant Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Aerospace & Defense

Symbol Name Price(Change) Market Cap
RKLB Rocket Lab USA Inc.

+0.72 (+2.90%)

USD 12.21B
WWD Woodward Inc

+1.52 (+0.90%)

USD 10.60B
AVAV AeroVironment Inc

-2.83 (-1.73%)

USD 4.43B
KTOS Kratos Defense & Security Solu..

+0.12 (+0.46%)

USD 4.18B
VSEC VSE Corporation

-1.21 (-1.22%)

USD 2.42B
MRCY Mercury Systems Inc

+0.60 (+1.51%)

USD 2.29B
EH Ehang Holdings Ltd

-0.04 (-0.27%)

USD 0.95B
ATRO Astronics Corporation

-0.13 (-0.82%)

USD 0.58B
SWBI Smith & Wesson Brands Inc

-0.19 (-1.89%)

USD 0.48B
BYRN Byrna Technologies Inc

-0.36 (-1.22%)

USD 0.44B

ETFs Containing AXON

XAR SPDR® S&P Aerospace & De.. 7.06 % 0.35 %

-0.62 (0%)

USD 2.91B
NATO Themes Transatlantic Defe.. 5.83 % 0.00 %

-0.05 (0%)

USD 1.56M
GUNZ 5.72 % 0.00 %

N/A

N/A
CNAV 4.69 % 0.00 %

N/A

N/A
PPA Invesco Aerospace & Defen.. 4.66 % 0.59 %

-0.22 (0%)

USD 4.55B
XAD:CA iShares U.S. Aerospace & .. 4.42 % 0.00 %

-0.03 (0%)

N/A
EQQJ:XETRA Invesco NASDAQ Next Gener.. 3.16 % 0.00 %

-0.19 (0%)

USD 0.05B
EQJS:LSE Invesco NASDAQ Next Gener.. 3.09 % 0.00 %

-7.50 (0%)

USD 0.05B
TMFX Motley Fool Next Index ET.. 2.40 % 0.00 %

N/A

USD 0.03B
IQCT:LSE Amundi Index Solutions - .. 2.34 % 0.00 %

-0.33 (0%)

USD 0.07B
RSPN Invesco S&P 500 Equal Wei.. 1.92 % 0.00 %

-0.19 (0%)

USD 0.70B
FXR First Trust Industrials/P.. 1.89 % 0.62 %

-0.05 (0%)

USD 1.95B
FHG:CA FT AlphaDEX U.S. Industri.. 1.82 % 0.76 %

+0.26 (+0%)

CAD 0.04B
VBK Vanguard Small-Cap Growth.. 1.56 % 0.07 %

-0.59 (0%)

USD 20.12B
EQQJ:LSE Invesco NASDAQ Next Gener.. 1.55 % 0.00 %

-0.30 (0%)

N/A
IWP iShares Russell Mid-Cap G.. 1.45 % 0.24 %

-0.38 (0%)

USD 17.84B
QWST 1.36 % 0.00 %

N/A

N/A
SCITY:PA 1.27 % 0.00 %

N/A

N/A
SCITY:SW Amundi Index Solutions - .. 1.27 % 0.00 %

+0.94 (+0%)

USD 0.07B
IQCY:LSE Amundi Index Solutions - .. 1.25 % 0.00 %

-0.03 (0%)

N/A
MMSC First Trust Multi-Manager.. 1.12 % 0.00 %

-0.08 (0%)

USD 0.03B
SEIS SEI Select Small Cap ETF 1.05 % 0.00 %

-0.02 (0%)

USD 0.24B
FEX:LSE First Trust US Large Cap .. 0.69 % 0.00 %

-8.00 (0%)

USD 0.23B
FEXD:LSE First Trust US Large Cap .. 0.69 % 0.00 %

-8.00 (0%)

USD 0.04B
FEXU:LSE First Trust Global Funds .. 0.69 % 0.00 %

-0.55 (0%)

USD 0.23B
JPSC:XETRA JPMorgan BetaBuilders US .. 0.41 % 0.00 %

-0.30 (0%)

N/A
BFOR Barron's 400 ETF 0.37 % 0.65 %

+0.05 (+0%)

USD 0.15B
ISPE:LSE iShares S&P 500 Equal Wei.. 0.32 % 0.00 %

-0.05 (0%)

USD 0.66B
XDEW:XETRA Xtrackers S&P 500 Equal W.. 0.32 % 0.00 %

-0.57 (0%)

USD 2.73B
XDED:XETRA Xtrackers S&P 500 Equal W.. 0.32 % 0.00 %

-0.51 (0%)

USD 13.46B
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.32 % 0.00 %

-0.29 (0%)

USD 0.21B
SP2Q:XETRA Invesco S&P 500 Equal Wei.. 0.32 % 0.00 %

-0.10 (0%)

USD 0.84B
XDEW:F Xtrackers (IE) Public Lim.. 0.31 % 0.00 %

-0.09 (0%)

USD 12.94B
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.31 % 0.00 %

-0.07 (0%)

USD 14.52B
XDEW:SW Xtrackers S&P 500 Equal W.. 0.31 % 0.00 %

+0.56 (+0%)

USD 13.34B
XEWG:LSE Xtrackers S&P 500 Equal W.. 0.31 % 0.00 %

-0.05 (0%)

USD 0.09B
QUS:AU BetaShares S&P 500 Equal .. 0.31 % 0.00 %

+0.84 (+0%)

USD 0.58B
SPED:LSE Invesco S&P 500 Equal Wei.. 0.31 % 0.00 %

-0.37 (0%)

USD 0.15B
SPEQ:LSE Invesco S&P 500 Equal Wei.. 0.31 % 0.00 %

-0.11 (0%)

USD 0.63B
CHEP 0.00 % 1.12 %

N/A

N/A
FAD First Trust Multi Cap Gro.. 0.00 % 0.69 %

-0.11 (0%)

USD 0.23B
FEX First Trust Large Cap Cor.. 0.00 % 0.61 %

+0.13 (+0%)

USD 1.36B
FTC First Trust Large Cap Gro.. 0.00 % 0.61 %

-0.62 (0%)

USD 1.19B
ITA 0.00 % 0.42 %

N/A

N/A
PRN Invesco DWA Industrials M.. 0.00 % 0.00 %

-0.73 (0%)

USD 0.43B
RNSC First Trust Small Cap US .. 0.00 % 0.60 %

N/A

USD 0.03B
SCHM Schwab U.S. Mid-Cap ETF 0.00 % 0.05 %

+0.06 (+0%)

N/A
VB Vanguard Small-Cap Index .. 0.00 % 0.05 %

-0.85 (0%)

N/A
DFEN Direxion Daily Aerospace .. 0.00 % 1.09 %

-0.04 (0%)

USD 0.17B
IUSF:LSE iShares IV Public Limited.. 0.00 % 0.00 %

-2.38 (0%)

USD 0.29B
IUSZ:LSE iShares Edge MSCI USA Siz.. 0.00 % 0.00 %

-0.09 (0%)

USD 0.29B
BFTR 0.00 % 0.00 %

N/A

N/A
JOET Virtus ETF Trust II 0.00 % 0.00 %

+0.01 (+0%)

USD 0.15B
QQQJ Invesco NASDAQ Next Gen 1.. 0.00 % 0.00 %

+0.03 (+0%)

USD 0.69B
QQQN 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Aerospace & Defense) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 144.53% 79% B- 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 144.53% 79% B- 95% A
Trailing 12 Months  
Capital Gain 143.87% 81% B- 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 143.87% 81% B- 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 29.66% 67% D+ 80% B-
Dividend Return 29.66% 67% D+ 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 49.15% 36% F 39% F
Risk Adjusted Return 60.34% 82% B 84% B
Market Capitalization 1.28B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Aerospace & Defense) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 164.08 19% 8%
Price/Book Ratio 22.94 12% 6%
Price / Cash Flow Ratio 254.51 7% 1%
Price/Free Cash Flow Ratio 116.92 8% 3%
Management Effectiveness  
Return on Equity 16.42% 96% 86%
Return on Invested Capital 8.22% 74% 74%
Return on Assets 2.29% 72% 74%
Debt to Equity Ratio 42.00% 22% 45%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.